# A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia

> **NCT01407289** · PHASE4 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 74 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin Aspart, Insulin Glargine

## Key facts

- **NCT ID:** NCT01407289
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01407289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01407289, "A Trial to Investigate Efficacy and Usability of Published Best Practice to Control Glycaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01407289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*